AJP Legacy AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 195: 331-336, 1958;
0002-9513/58 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotspeich, W. D.
Right arrow Articles by Woronkow, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotspeich, W. D.
Right arrow Articles by Woronkow, S.

Some Quantitative Studies on Phlorizin Inhibition of Glucose Transport in the Kidney

William D. Lotspeich 1 and Seraphim Woronkow 1

1 From the Department of Physiology, College of Medicine, University of Cincinnati, Cincinnati, Ohio

The constant infusion of phlorizin in small amounts (0.6–100 µg/kg/min.) reduces maximal glucose transport rate (Tmg) by 20–70% in dogs. Thus phlorizin is a much more powerful inhibitor of glucose transport than hitherto supposed. From these experiments it is reasonable to conclude that effective phlorizin concentrations in the intact animal are in the same range as those shown to produce effects on sugar transport and oxidative metabolism in vitro. Complete inhibition of glucose transport during constant infusion of phlorizin was never produced even at rates of 100 µg/kg/min. Experiments on citrate metabolism in vitro and Tmg in vivo show that phlorizin does not act at a site sensitive to 2,4-dinitrophenol. The findings presented are discussed in the light of a cell membrane theory of phlorizin action.

Submitted on May 2, 1958







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1958 by the American Physiological Society.